Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Rock Creek Pharmaceuticals Inc

STSI:US

Ticker Change

Company Profile for Rock Creek Pharmaceuticals Inc (STSI)

Rock Creek Pharmaceuticals, Inc. is a drug development company focused on the discovery, development and commercialization of new drugs, formulations and compounds that provide therapies for chronic inflammatory disease, neurologic disorders and behavioral health.

Contact Information

Rock Creek Pharmaceuticals Inc

2040 Whitfield Avenue
Suite 300
Sarasota, FL 34243
United States
Phone: 1-804-527-1970

Key Executives for Rock Creek Pharmaceuticals Inc (STSI)

Michael John MullanChairman/CEOChristopher C Chapman JrPresident
Paul L PeritoVP/General Counsel/ConsultantBenjamin M Dent "Don"VP:Operations/CFO/Secy

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil